Skip to content

Abnormal Circulating Cystatin C Concentration C5397987

Published: July 22, 2026Updated: August 20, 2026

Cystatin C is a protein used to assess kidney function. Abnormal concentrations may indicate kidney impairment or disease. Management involves monitoring kidney health and treating any underlying kidney condition.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
N28.9
ICD-11
GA00.0
Body system
renal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Shortness of breath

Difficulty breathing or feeling winded, often due to fluid accumulation in the lungs from reduced kidney function.

Seek immediate medical attention if experiencing sudden or severe shortness of breath or chest pain.

!

Confusion or altered mental status

Confusion, difficulty concentrating, or changes in mental alertness due to toxin accumulation affecting brain function.

Seek immediate medical attention for any sudden confusion, severe headache, or loss of consciousness.

Fatigue and weakness

(constitutional)

Persistent feeling of tiredness, low energy, and general weakness that is not relieved by rest.

Frequency: 70-80% of patients

Peripheral edema

(renal)

Swelling in the legs, ankles, feet, or around the eyes due to fluid retention from impaired kidney function.

Frequency: 50-60% of patients

Changes in urination

(renal)

Altered urination patterns including increased or decreased frequency, foamy urine, or blood in urine.

Frequency: 45-55% of patients

Nausea and vomiting

(gastrointestinal)

Feeling sick to the stomach with urge to vomit, often related to toxin buildup when kidneys cannot filter properly.

Frequency: 30-40% of patients

High blood pressure

(cardiovascular)

Elevated blood pressure due to fluid and sodium retention and impaired kidney regulation of blood pressure.

Frequency: 60-70% of patients

Itchy skin

(dermatologic)

Persistent itching or dry skin caused by mineral imbalances and toxin buildup in the blood.

Frequency: 15-25% of patients

Metallic taste in mouth

(neurologic)

Persistent altered taste or metallic/diminished sense of taste due to metabolic changes.

Frequency: 10-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Renal disease management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Renal function tracking

Regular assessment of cystatin C levels and related kidney markers to detect changes early and guide intervention.

monitoring
3

Kidney-friendly nutrition

Reduced sodium, controlled protein, and balanced electrolyte intake to support optimal kidney filtration function.

dietary

Additional treatment options

Blood pressure optimization

Weight management, regular activity, and sodium control to maintain healthy blood pressure supporting kidney function.

lifestyle

Nephroprotective agents

Medications that provide kidney protection and reduce proteinuria under physician supervision.

medication

Renal imaging assessment

Diagnostic imaging to evaluate kidney structure and rule out obstructive causes or structural abnormalities affecting function.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Cystatin C Concentration C5397987?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Workgroup. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements. 2012;3(1):1-150.

guideline2012View source →
2

Clinical and Laboratory Standards Institute. Measurement of Glomerular Filtration Rate Using Cystatin C. CLSI Guideline EP07. 2018.

guideline2018View source →
3

Inker LA, Shafi T. Novel biomarkers for kidney disease: cystatin C. In: Gilbert SJ, Weiner DE, editors. National Kidney Foundation Primer on Kidney Diseases. 7th ed. Elsevier; 2018:45-52.

review2018
4

Shlipak MG, Matsushita K, Arnlov J, et al. Cystatin C versus creatinine in determining risk based on kidney function. New England Journal of Medicine. 2013;369(10):932-943.

meta_analysis2013View source →
5

Inker LA, Wyatt C, Feldman J, et al. Cystatin C as a filtration marker: accuracy and implications for clinical use. Kidney International. 2012;81(8):779-789.

clinical_trial2012View source →
6

Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A. Cystatin C as a marker of GFR—history, indications, and future research. Clinical Biochemistry. 2005;38(1):1-8.

review2005View source →
7

Zhang X, McCulloch CE, Lin F, et al. Accuracy of cystatin C-based equations for glomerular filtration rate estimation in multiple populations: a systematic review. Annals of Internal Medicine. 2013;158(7):518-527.

meta_analysis2013View source →
8

National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases. 2002;39(2 Suppl 1):S1-266.

position_statement2002View source →
9

Grubb A. Cystatin C as a biomarker: estimating glomerular filtration rate (GFR) and prospects for use worldwide. Clinical Biochemistry. 2015;48(6):377-380.

review2015View source →
10

European Medicines Agency. Guideline on the Evaluation of Renal Function. EMA/CHMP/116770/2018. 2018.

Medication Comparisons

Compare medications used to treat Abnormal Circulating Cystatin C Concentration C5397987. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy